These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


298 related items for PubMed ID: 24942021

  • 1. Therapy-induced secondary acute myeloid leukemia with t(11;19)(q23;p13.1) in a pediatric patient with relapsed acute promyelocytic leukemia.
    Dang DN, Morris HD, Feusner JH, Koduru P, Wilson K, Timmons CF, Cavalier M, Luu HS.
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):e546-8. PubMed ID: 24942021
    [Abstract] [Full Text] [Related]

  • 2. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
    Lee GY, Christina S, Tien SL, Ghafar AB, Hwang W, Lim LC, Lim TH.
    Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
    [Abstract] [Full Text] [Related]

  • 3. Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci.
    Hasan SK, Ottone T, Schlenk RF, Xiao Y, Wiemels JL, Mitra ME, Bernasconi P, Di Raimondo F, Stanghellini MT, Marco P, Mays AN, Döhner H, Sanz MA, Amadori S, Grimwade D, Lo-Coco F.
    Genes Chromosomes Cancer; 2010 Aug; 49(8):726-32. PubMed ID: 20544846
    [Abstract] [Full Text] [Related]

  • 4. Molecular analysis of the t(15;17) translocation in de novo and secondary acute promyelocytic leukemia.
    Naoe T, Kudo K, Yoshida H, Horibe K, Ohno R.
    Leukemia; 1997 Apr; 11 Suppl 3():287-8. PubMed ID: 9209367
    [Abstract] [Full Text] [Related]

  • 5. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS, Choi JR, Yoon SH, Song J, Kim J, Kim SJ, Kwon O, Min YH.
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [Abstract] [Full Text] [Related]

  • 6. ider(17)(q10)t(15;17) associated with relapse and poor prognosis in a pediatric patient with acute promyelocytic leukemia.
    Kim MJ, Yoon HS, Cho SY, Lee HJ, Suh JT, Lee J, Yoon HJ, Lee WI, Park TS.
    Cancer Genet Cytogenet; 2010 Sep; 201(2):116-21. PubMed ID: 20682396
    [Abstract] [Full Text] [Related]

  • 7. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ, Wang ZY, Chen Z.
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [Abstract] [Full Text] [Related]

  • 8. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
    Chen Z, Tong JH, Dong S, Zhu J, Wang ZY, Chen SJ.
    Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
    [Abstract] [Full Text] [Related]

  • 9. Acute promyelocytic leukaemia and the t(15;17) translocation.
    Gillard EF, Solomon E.
    Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
    [Abstract] [Full Text] [Related]

  • 10. Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
    Slack JL, Arthur DC, Lawrence D, Mrózek K, Mayer RJ, Davey FR, Tantravahi R, Pettenati MJ, Bigner S, Carroll AJ, Rao KW, Schiffer CA, Bloomfield CD.
    J Clin Oncol; 1997 May; 15(5):1786-95. PubMed ID: 9164186
    [Abstract] [Full Text] [Related]

  • 11. Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts.
    Park TS, Lee ST, Kim JS, Song J, Lee KA, Kim SJ, Seok YM, Lee HJ, Han JH, Kim JK, Lee EY, Choi JR.
    Cancer Genet Cytogenet; 2009 Jan 01; 188(1):48-51. PubMed ID: 19061780
    [Abstract] [Full Text] [Related]

  • 12. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ, Nason-Burchenal K, Moasser MM, Dmitrovsky E.
    Oncogene; 1995 Jun 15; 10(12):2307-14. PubMed ID: 7784078
    [Abstract] [Full Text] [Related]

  • 13. Acute promyelocytic leukemia with i(17)(q10) on G-banding and PML/RARA rearrangement by RT-PCR without evidence of PML/RARA rearrangement on FISH.
    Huh J, Moon H, Chi H, Chung W.
    Int J Lab Hematol; 2009 Jun 15; 31(3):372-4. PubMed ID: 18294238
    [No Abstract] [Full Text] [Related]

  • 14. Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha).
    Morikawa J, Li H, Kim S, Nishi K, Ueno S, Suh E, Dougherty E, Shmulevich I, Shiku H, Zhang W, Kobayashi T.
    Int J Oncol; 2003 Sep 15; 23(3):617-25. PubMed ID: 12888896
    [Abstract] [Full Text] [Related]

  • 15. A new variant translocation in acute promyelocytic leukaemia: molecular characterization and clinical correlation.
    Wells RA, Hummel JL, De Koven A, Zipursky A, Kirby M, Dubé I, Kamel-Reid S.
    Leukemia; 1996 Apr 15; 10(4):735-40. PubMed ID: 8618456
    [Abstract] [Full Text] [Related]

  • 16. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
    Rousselot P, Hardas B, Patel A, Guidez F, Gäken J, Castaigne S, Dejean A, de Thé H, Degos L, Farzaneh F.
    Oncogene; 1994 Feb 15; 9(2):545-51. PubMed ID: 8290265
    [Abstract] [Full Text] [Related]

  • 17. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
    Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, Pandolfi PP.
    Oncogene; 2006 Mar 23; 25(13):1974-9. PubMed ID: 16331271
    [Abstract] [Full Text] [Related]

  • 18. Mutations affecting both the rearranged and the unrearranged PML alleles in refractory acute promyelocytic leukaemia.
    Iaccarino L, Ottone T, Divona M, Cicconi L, Cairoli R, Voso MT, Lo-Coco F.
    Br J Haematol; 2016 Mar 23; 172(6):909-13. PubMed ID: 26728337
    [Abstract] [Full Text] [Related]

  • 19. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
    Chen SJ, Chen LJ, Zhou GB.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb 23; 13(1):1-8. PubMed ID: 15748426
    [Abstract] [Full Text] [Related]

  • 20. Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia.
    Mays AN, Osheroff N, Xiao Y, Wiemels JL, Felix CA, Byl JA, Saravanamuttu K, Peniket A, Corser R, Chang C, Hoyle C, Parker AN, Hasan SK, Lo-Coco F, Solomon E, Grimwade D.
    Blood; 2010 Jan 14; 115(2):326-30. PubMed ID: 19884644
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.